Jerome M. Adams - 18 May 2021 Form 4 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Role
Director
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Jerome M. Adams
Issuer symbol
AVIR
Transactions as of
18 May 2021
Net transactions value
$0
Form type
4
Filing time
20 May 2021, 18:27:28 UTC
Next filing
21 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVIR Stock Option (Right to Buy) Award $0 +56,670 $0.000000 56,670 18 May 2021 Common Stock 56,670 $23.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in thirty-six (36) equal monthly installments following May 18, 2021.